Inventor · San Jose, CA, US

William D. Thomas

41Patents
11h-index
76Co-inventors
78Inventor score

Filing activity: Oct 16, 1995 → Sep 28, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US6214341A Passive immunization against Clostridium difficile disease Human Necessities 59 Expired
US6969520B2 Active immunization against clostridium difficile disease Physics 57 Expired
US6680168B2 Passive immunization against clostridium difficile disease Human Necessities 52 Expired
US5919463A Clostridium difficle toxins as mucosal adjuvants Emerging Cross-Sectional Technologies 34 Expired
US7718683B2 Triazolyl phenyl benzenesulfonamides Chemistry; Metallurgy 33 Active
US7625559B2 Antibodies against Clostridium difficile toxins and uses thereof Emerging Cross-Sectional Technologies 29 Active
US7807704B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 Chemistry; Metallurgy 26 Active
US9266827B2 Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 22 Active
US9512111B2 N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Chemistry; Metallurgy 21 Active
US9657033B2 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Chemistry; Metallurgy 19 Active
US8257709B2 Antibodies against Clostridium difficile toxins and uses thereof Emerging Cross-Sectional Technologies 16 Active
US5985631A Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease Human Necessities 9 Expired
US7776877B2 N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides Chemistry; Metallurgy 8 Active
US8236311B2 Antibodies against clostridium difficile toxins and uses thereof Emerging Cross-Sectional Technologies 8 Active
US9809561B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 8 Active
US5837240A Multimeric, recombinant urease vaccine Human Necessities 7 Expired
US8226952B2 Human antibodies against rabies and uses thereof Chemistry; Metallurgy 6 Active
US10221146B2 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Emerging Cross-Sectional Technologies 6 Active
US7396914B2 SARS nucleic acids, proteins, antibodies, and uses thereof Physics 5 Expired
US10377768B2 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Chemistry; Metallurgy 5 Active
US8153818B2 Triazolyl phenyl benzenesulfonamides Chemistry; Metallurgy 3 Active
US8609111B2 Antibodies against clostridium difficile toxins and uses thereof Emerging Cross-Sectional Technologies 3 Active
US7727532B2 Human antibodies against rabies and uses thereof Chemistry; Metallurgy 3 Active
US10774045B2 Compounds for modulating mitochondrial function Chemistry; Metallurgy 2 Active
US10336700B2 Compounds for modulating mitochondrial function Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.